T-curx (private company)
See something wrong or missing? Let us know
Offices:Munich
Business model:B2B
T-curx is a pharma startup in Germany which develops non-viral cell therapies for blood cancers, leveraging a proprietary platform for improved patient outcomes.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 20.46M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to T-curx
| Name | Criteria | |
|---|---|---|
![]() |
Ability Pharma
70%
|
|
![]() |
AbolerIS Pharma
70%
|
|
![]() |
Acesion Pharma
70%
|
|
![]() |
Beckley Psytech
70%
|
|
![]() |
CatalYm
70%
|
|
![]() |
Citryll
70%
|
|
![]() |
Inbrain Neuroelectronics
70%
|
|
![]() |
InnovaFeed SAS
70%
|
|
![]() |
Memo Therapeutics
70%
|
|
![]() |
NMD Pharma
70%
|
|







Belgium
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal